Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Waxman

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Clinical Journal of Oncology Nursing|August 5, 2010
A case study progression to multiple myelomaMary Ann Yancey, Adam J Waxman, Ola Landgren
Clinical Lymphoma, Myeloma & Leukemia|August 17, 2010
Smoldering (asymptomatic) multiple myeloma: revisiting the clinical dilemma and looking into the futureAdam J Waxman, Michael Kuehl, Arun Balakumaran, et al.
European Journal of Haematology|November 18, 2024
Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL AmyloidosisMargaret Stalker, Alfred Garfall, Adam Cohen, et al.
Blood|September 9, 2010
Racial disparities in incidence and outcome in multiple myeloma: a population-based studyAdam J Waxman, Pamela J Mink, Susan S Devesa, et al.
Advances in Radiation Oncology|August 19, 2021
Radiation Therapy for Plasma Cell Disease of the Brain and Skull: Poor Palliation and Survival After Treatment for Central Nervous System InvolvementGraeme R Williams, Anish A Butala, Shwetha H Manjunath, et al.
Journal of the American College of Cardiology|January 19, 2019
Cardiovascular Function Phenotypes in Response to Cardiotoxic Breast Cancer TherapyBiniyam G Demissei, Brian S Finkelman, Rebecca A Hubbard, et al.
JAMA Oncology|December 30, 2017
Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysisAdam J Waxman, Suparna Clasen, Wei-Ting Hwang, et al.
European Journal of Haematology|December 5, 2022
Progressive multifocal leukoencephalopathy in multiple myelomaBrian W Hoeynck, Adam D Cohen, Edward A Stadtmauer, et al.
Haematologica|February 6, 2025
Non-tuberculous mycobacterial infections following teclistamab in multiple myelomaMatthew Ho, Luca Paruzzo, Janna Minehart, et al.
American Journal of Hematology|June 12, 2016
Proteasome inhibitor associated thrombotic microangiopathyJennifer C Yui, Jan Van Keer, Brendan M Weiss, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Clinical Journal of Oncology Nursing|August 5, 2010
A case study progression to multiple myelomaMary Ann Yancey, Adam J Waxman, Ola Landgren
Clinical Lymphoma, Myeloma & Leukemia|August 17, 2010
Smoldering (asymptomatic) multiple myeloma: revisiting the clinical dilemma and looking into the futureAdam J Waxman, Michael Kuehl, Arun Balakumaran, et al.
European Journal of Haematology|November 18, 2024
Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL AmyloidosisMargaret Stalker, Alfred Garfall, Adam Cohen, et al.
Blood|September 9, 2010
Racial disparities in incidence and outcome in multiple myeloma: a population-based studyAdam J Waxman, Pamela J Mink, Susan S Devesa, et al.
Advances in Radiation Oncology|August 19, 2021
Radiation Therapy for Plasma Cell Disease of the Brain and Skull: Poor Palliation and Survival After Treatment for Central Nervous System InvolvementGraeme R Williams, Anish A Butala, Shwetha H Manjunath, et al.
Journal of the American College of Cardiology|January 19, 2019
Cardiovascular Function Phenotypes in Response to Cardiotoxic Breast Cancer TherapyBiniyam G Demissei, Brian S Finkelman, Rebecca A Hubbard, et al.
JAMA Oncology|December 30, 2017
Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysisAdam J Waxman, Suparna Clasen, Wei-Ting Hwang, et al.
European Journal of Haematology|December 5, 2022
Progressive multifocal leukoencephalopathy in multiple myelomaBrian W Hoeynck, Adam D Cohen, Edward A Stadtmauer, et al.
Haematologica|February 6, 2025
Non-tuberculous mycobacterial infections following teclistamab in multiple myelomaMatthew Ho, Luca Paruzzo, Janna Minehart, et al.
American Journal of Hematology|June 12, 2016
Proteasome inhibitor associated thrombotic microangiopathyJennifer C Yui, Jan Van Keer, Brendan M Weiss, et al.
Pageof 2